Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

ClinicalTrials.gov ID: NCT07215559

Public ClinicalTrials.gov record NCT07215559. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 5:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Reduction With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight and With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate weight reduction with macupatide and eloralintide, alone or in combination, in adult participants with obesity or overweight and with type 2 diabetes. Participation in the study will last about 48 weeks.

Study identification

NCT ID
NCT07215559
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
200 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 16, 2025 (Actual)
Primary completion
Mar 2027 (Estimated)
Completion
May 2027 (Estimated)
Last update posted
Oct 9, 2026

2025 – 2027

United States locations

U.S. sites
26
U.S. states
10
U.S. cities
23
Facility City State ZIP Site status
Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC Gilbert Arizona 85296 —
Synexus Clinical Research US, Inc. Phoenix Arizona 85020 —
Pima Heart Tucson Arizona 85741 —
Precision Clinical Research Sunrise Florida 33351 —
SKY Clinical Research Network Group-Brown Atlanta Georgia 30331 —
Teak Research Consults Lawrenceville Georgia 30043 —
AGILE Clinical Research Trials, LLC Sandy Springs Georgia 30328 —
Pivotal Research Solutions Stonecrest Georgia 30038 —
Rophe Adult and Pediatric Medicine/SKYCRNG Union City Georgia 30291 —
Vector Clinical Trials Las Vegas Nevada 89128 —
Premier Research Trenton New Jersey 08611 —
PriMED Clinical Research Dayton Ohio 45429 —
Mercy Family Clinic Dallas Texas 75208 —
Velocity Clinical Research, Dallas Dallas Texas 75230 —
Biopharma Informatic, LLC Houston Texas 77043 —
PlanIt Research, PLLC Houston Texas 77079 —
Research Physicians Network, LLC Houston Texas 77089 —
Aavon Clinical Trials Richmond Texas 77407 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —
Texas Valley Clinical Research Weslaco Texas 78596 —
Kalo Clinical Research West Valley City Utah 84120 —
Eastern Virginia Medical School (EVMS) Medical Group Norfolk Virginia 23510 —
Clinical Research Partners, LLC Richmond Virginia 23226 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Rainier Clinical Research Center Renton Washington 98057 —
Universal Research Group Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07215559, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 9, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07215559 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →